Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings highlight that oxidative stress could activate T14 in the adult brain through AChE upregulation, contributing to neurodegeneration in Alzheimer’s disease.
LATEST NEWS
- Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference
- Meeting with Prof. Lorna Harries at the University of Exeter to review progress and plan next experiments
- Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
- Neuro-Bio welcomes back Adam Khan